Register now!

The Research Working Group seeks to bridge the missing mile between basic research and the commercialization of products. Having an equal partnership between the Virtual Physiological Human Institute (VPH) and industries engaged in predictive medicine provides a unique opportunity to explore areas of mutual cooperation and benefit.

The key goals of this group are:

  • Promotion of in silico medicine in Horizon 2020;
  • Working towards the creation of a Public Private Partnership (PPP) on in silico medicine;
  • Creating links between the VPH Membership and Avicenna Industry Members


Priorities in 2017

→ Contribute to the Avicenna Alliance Policy Recommendations on in silico medicine to be submitted to the European Commission;
→ Develop draft suggested Call Texts for proposals for the “Health, Demographic Change and Well-being” sections for Horizon 2020;

Avicenna Alliance news

Avicenna Alliance founding Sec Gen leaves legacy of policy success

As the Avicenna Alliance enters its 3rd year of operation in 2018, it brings with it a change in management and a huge upscaling of...

find out more ›

And the EMA goes to… Amsterdam!

During a General Affairs Council meeting on 20 November, the EU27 ministers decided on the new location of the European Medicines Agency (EMA) and the European Banking...

find out more ›

Commission adopts 2018 Work Programme

Following on from the announcements made in President Juncker's 2017 State of the Union Address, the European Commission adopted on 24 October 2017 its 2018 Work...

find out more ›

Show all activites